San Francisco, United States
Sempre Health, founded in 2015, is revolutionizing the healthcare industry with its innovative approach to pricing through behavior-based, individualized copays. By collaborating with health plans and pharmaceutical manufacturers, the company dynamically adjusts copays according to patient adherence and behavior at the point of fill.
Leveraging behavioral economics and SMS technology, Sempre Health incentivizes patients who regularly take their medications with reduced costs over time, driving long-term behavioral change and significant savings in healthcare expenditure. Their data-driven methodology can parse millions of prescription records to determine the optimal price for each patient, seamlessly integrating these calculations at pharmacies across the United States.
In September 2023, Sempre Health secured a $20.00M Series C investment from notable investors including Industry Ventures, Echo Health Ventures, The Blue Venture Fund, UPMC Enterprises, and Cencora, signaling strong industry confidence in its disruptive healthcare solution.
Compliance Meds Technologies
